 | • レポートコード：GIR-22F19398 • 出版社/出版日：GlobalInfoResearch / 2022年11月 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Human Rabies Vaccination Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社の最新の調査によると、世界の人間用狂犬病予防接種の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 人間用狂犬病予防接種市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次をカバーします。 ・Vero細胞、BHK、ニワトリ胚細胞、ヒト二倍体細胞、その他 アプリケーション別セグメントは次のように区分されます。 ・前露光、後露光 世界の人間用狂犬病予防接種市場の主要な市場プレーヤーは以下のとおりです。 ・Bharat Biotech、Bavarian Nordic、Sanofi-Pasteur、Chengda Bio、KANGH、Prcmise、Henan Grand Biopharma、Zhuoyi Biological、ZhongKe Biopharm、Ningbo Rongan Biological、Indian Immunologicals 地域別セグメントは次の地域・国をカバーします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、人間用狂犬病予防接種製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な人間用狂犬病予防接種メーカーの企業概要、2019年～2022年までの人間用狂犬病予防接種の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な人間用狂犬病予防接種メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別人間用狂犬病予防接種の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの人間用狂犬病予防接種のタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での人間用狂犬病予防接種市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および人間用狂犬病予防接種の産業チェーンを掲載しています。 ・第13、14、15章では、人間用狂犬病予防接種の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - 人間用狂犬病予防接種の概要 - タイプ別分析（2017年vs2021年vs2028年）：Vero細胞、BHK、ニワトリ胚細胞、ヒト二倍体細胞、その他 - アプリケーション別分析（2017年vs2021年vs2028年）：前露光、後露光 - 世界の人間用狂犬病予防接種市場規模・予測 - 世界の人間用狂犬病予防接種生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Bharat Biotech、Bavarian Nordic、Sanofi-Pasteur、Chengda Bio、KANGH、Prcmise、Henan Grand Biopharma、Zhuoyi Biological、ZhongKe Biopharm、Ningbo Rongan Biological、Indian Immunologicals ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：Vero細胞、BHK、ニワトリ胚細胞、ヒト二倍体細胞、その他 ・アプリケーション別分析2017年-2028年：前露光、後露光 ・人間用狂犬病予防接種の北米市場分析 - 人間用狂犬病予防接種の北米市場：タイプ別市場規模2017年-2028年 - 人間用狂犬病予防接種の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・人間用狂犬病予防接種のヨーロッパ市場分析 - ：人間用狂犬病予防接種のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：人間用狂犬病予防接種のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・人間用狂犬病予防接種のアジア太平洋市場分析 - 人間用狂犬病予防接種のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 人間用狂犬病予防接種のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・人間用狂犬病予防接種の南米市場分析 - 人間用狂犬病予防接種の南米市場：タイプ別市場規模2017年-2028年 - 人間用狂犬病予防接種の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・人間用狂犬病予防接種の中東・アフリカ市場分析 - 人間用狂犬病予防接種の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 人間用狂犬病予防接種の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Human Rabies Vaccination market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Human Rabies Vaccination market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Pre-exposure accounting for % of the Human Rabies Vaccination global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Vero Cell segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Human Rabies Vaccination include Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, Chengda Bio, and KANGH, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Human Rabies Vaccination market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Vero Cell
BHK
Chick Embryo Cell
Human Diploid Cells
Others
Market segment by Application can be divided into
Pre-exposure
Post-exposure
The key market players for global Human Rabies Vaccination market are listed below:
Bharat Biotech
Bavarian Nordic
Sanofi-Pasteur
Chengda Bio
KANGH
Prcmise
Henan Grand Biopharma
Zhuoyi Biological
ZhongKe Biopharm
Ningbo Rongan Biological
Indian Immunologicals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Rabies Vaccination product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Rabies Vaccination, with price, sales, revenue and global market share of Human Rabies Vaccination from 2019 to 2022.
Chapter 3, the Human Rabies Vaccination competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Rabies Vaccination breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Human Rabies Vaccination market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Rabies Vaccination.
Chapter 13, 14, and 15, to describe Human Rabies Vaccination sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Human Rabies Vaccination Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Rabies Vaccination Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Vero Cell
1.2.3 BHK
1.2.4 Chick Embryo Cell
1.2.5 Human Diploid Cells
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Rabies Vaccination Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Pre-exposure
1.3.3 Post-exposure
1.4 Global Human Rabies Vaccination Market Size & Forecast
1.4.1 Global Human Rabies Vaccination Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Human Rabies Vaccination Sales in Volume (2017-2028)
1.4.3 Global Human Rabies Vaccination Price (2017-2028)
1.5 Global Human Rabies Vaccination Production Capacity Analysis
1.5.1 Global Human Rabies Vaccination Total Production Capacity (2017-2028)
1.5.2 Global Human Rabies Vaccination Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Rabies Vaccination Market Drivers
1.6.2 Human Rabies Vaccination Market Restraints
1.6.3 Human Rabies Vaccination Trends Analysis
2 Manufacturers Profiles
2.1 Bharat Biotech
2.1.1 Bharat Biotech Details
2.1.2 Bharat Biotech Major Business
2.1.3 Bharat Biotech Human Rabies Vaccination Product and Services
2.1.4 Bharat Biotech Human Rabies Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Bavarian Nordic
2.2.1 Bavarian Nordic Details
2.2.2 Bavarian Nordic Major Business
2.2.3 Bavarian Nordic Human Rabies Vaccination Product and Services
2.2.4 Bavarian Nordic Human Rabies Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sanofi-Pasteur
2.3.1 Sanofi-Pasteur Details
2.3.2 Sanofi-Pasteur Major Business
2.3.3 Sanofi-Pasteur Human Rabies Vaccination Product and Services
2.3.4 Sanofi-Pasteur Human Rabies Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Chengda Bio
2.4.1 Chengda Bio Details
2.4.2 Chengda Bio Major Business
2.4.3 Chengda Bio Human Rabies Vaccination Product and Services
2.4.4 Chengda Bio Human Rabies Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 KANGH
2.5.1 KANGH Details
2.5.2 KANGH Major Business
2.5.3 KANGH Human Rabies Vaccination Product and Services
2.5.4 KANGH Human Rabies Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Prcmise
2.6.1 Prcmise Details
2.6.2 Prcmise Major Business
2.6.3 Prcmise Human Rabies Vaccination Product and Services
2.6.4 Prcmise Human Rabies Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Henan Grand Biopharma
2.7.1 Henan Grand Biopharma Details
2.7.2 Henan Grand Biopharma Major Business
2.7.3 Henan Grand Biopharma Human Rabies Vaccination Product and Services
2.7.4 Henan Grand Biopharma Human Rabies Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Zhuoyi Biological
2.8.1 Zhuoyi Biological Details
2.8.2 Zhuoyi Biological Major Business
2.8.3 Zhuoyi Biological Human Rabies Vaccination Product and Services
2.8.4 Zhuoyi Biological Human Rabies Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 ZhongKe Biopharm
2.9.1 ZhongKe Biopharm Details
2.9.2 ZhongKe Biopharm Major Business
2.9.3 ZhongKe Biopharm Human Rabies Vaccination Product and Services
2.9.4 ZhongKe Biopharm Human Rabies Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Ningbo Rongan Biological
2.10.1 Ningbo Rongan Biological Details
2.10.2 Ningbo Rongan Biological Major Business
2.10.3 Ningbo Rongan Biological Human Rabies Vaccination Product and Services
2.10.4 Ningbo Rongan Biological Human Rabies Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Indian Immunologicals
2.11.1 Indian Immunologicals Details
2.11.2 Indian Immunologicals Major Business
2.11.3 Indian Immunologicals Human Rabies Vaccination Product and Services
2.11.4 Indian Immunologicals Human Rabies Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Human Rabies Vaccination Breakdown Data by Manufacturer
3.1 Global Human Rabies Vaccination Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Human Rabies Vaccination Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Human Rabies Vaccination
3.4 Market Concentration Rate
3.4.1 Top 3 Human Rabies Vaccination Manufacturer Market Share in 2021
3.4.2 Top 6 Human Rabies Vaccination Manufacturer Market Share in 2021
3.5 Global Human Rabies Vaccination Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Human Rabies Vaccination Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Human Rabies Vaccination Market Size by Region
4.1.1 Global Human Rabies Vaccination Sales in Volume by Region (2017-2028)
4.1.2 Global Human Rabies Vaccination Revenue by Region (2017-2028)
4.2 North America Human Rabies Vaccination Revenue (2017-2028)
4.3 Europe Human Rabies Vaccination Revenue (2017-2028)
4.4 Asia-Pacific Human Rabies Vaccination Revenue (2017-2028)
4.5 South America Human Rabies Vaccination Revenue (2017-2028)
4.6 Middle East and Africa Human Rabies Vaccination Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Human Rabies Vaccination Sales in Volume by Type (2017-2028)
5.2 Global Human Rabies Vaccination Revenue by Type (2017-2028)
5.3 Global Human Rabies Vaccination Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Human Rabies Vaccination Sales in Volume by Application (2017-2028)
6.2 Global Human Rabies Vaccination Revenue by Application (2017-2028)
6.3 Global Human Rabies Vaccination Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Human Rabies Vaccination Sales by Type (2017-2028)
7.2 North America Human Rabies Vaccination Sales by Application (2017-2028)
7.3 North America Human Rabies Vaccination Market Size by Country
7.3.1 North America Human Rabies Vaccination Sales in Volume by Country (2017-2028)
7.3.2 North America Human Rabies Vaccination Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Human Rabies Vaccination Sales by Type (2017-2028)
8.2 Europe Human Rabies Vaccination Sales by Application (2017-2028)
8.3 Europe Human Rabies Vaccination Market Size by Country
8.3.1 Europe Human Rabies Vaccination Sales in Volume by Country (2017-2028)
8.3.2 Europe Human Rabies Vaccination Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Human Rabies Vaccination Sales by Type (2017-2028)
9.2 Asia-Pacific Human Rabies Vaccination Sales by Application (2017-2028)
9.3 Asia-Pacific Human Rabies Vaccination Market Size by Region
9.3.1 Asia-Pacific Human Rabies Vaccination Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Human Rabies Vaccination Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Human Rabies Vaccination Sales by Type (2017-2028)
10.2 South America Human Rabies Vaccination Sales by Application (2017-2028)
10.3 South America Human Rabies Vaccination Market Size by Country
10.3.1 South America Human Rabies Vaccination Sales in Volume by Country (2017-2028)
10.3.2 South America Human Rabies Vaccination Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Human Rabies Vaccination Sales by Type (2017-2028)
11.2 Middle East & Africa Human Rabies Vaccination Sales by Application (2017-2028)
11.3 Middle East & Africa Human Rabies Vaccination Market Size by Country
11.3.1 Middle East & Africa Human Rabies Vaccination Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Human Rabies Vaccination Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Human Rabies Vaccination and Key Manufacturers
12.2 Manufacturing Costs Percentage of Human Rabies Vaccination
12.3 Human Rabies Vaccination Production Process
12.4 Human Rabies Vaccination Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Human Rabies Vaccination Typical Distributors
13.3 Human Rabies Vaccination Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer